Unveiling the Impact of TRT on Cardiovascular Health

Screenshot (40105).webp

Screenshot (40106).webp

Screenshot (40107).webp
 
post #21

*We bring attention to the limitations of the TRAVERSE trial due to the potential for misleading reassurance of the safety of TRT at physiologic or supraphysiologic levels. The long term CV effects and the safety of such regimens have yet to be studied. We certainly advocate for further research to explore the long-term CV impact of TRT, especially at these higher dosing levels.

*The debate surrounding TRT and CVD risk thus far can be summarized as follows: current evidence suggests TRT does not increase CVD risk in older, hypogonadal men when administered over a short duration and at low-normal levels of replacement. The question remains open when considering the effects of TRT at physiologic or supraphysiologic levels.
 

Online statistics

Members online
0
Guests online
247
Total visitors
247

Latest posts

Back
Top